They used the serum for four weeks. Then they were asked: how much younger did they think they looked?
A single complaint lodged at a London tube station in late 2025 unravelled the scientific scaffolding behind a £49 face serum's promise of youth, reminding us that the desire to believe in transformation can outlast the evidence supporting it. Britain's Advertising Standards Authority ruled that Eucerin's claim of making users look five years younger rested on self-reported impressions, absent control groups, and studies that never tested the product itself. The ruling is modest in scope but pointed in implication: the beauty industry's language of clinical proof often borrows the authority of science without submitting to its discipline.
- A billboard at Balham tube station promised five years of youth for £49 — one observer found that promise worth challenging.
- The study underpinning the claim asked 160 people how much younger they felt after a month, with no control group, no objective measurement, and no clarity on who was even recruited.
- Beiersdorf's four pieces of supporting evidence included three unpublished studies and one peer-reviewed paper that tested an ingredient, not the serum consumers were actually buying.
- The ASA ruled the advert misleading and banned it from reappearing, while Beiersdorf noted the billboard had already been taken down and maintained its research met industry standards.
- Experts now urge consumers to press beauty brands on how skin quality is measured, which demographics were tested, and whether advertised results reflect typical or exceptional outcomes.
In November 2025, a single complaint about a billboard at Balham tube station in London triggered an investigation into Eucerin's Hyaluron-Filler Epigenetic Serum. The poster claimed the £49 product was clinically proven to make users look up to five years younger — a striking promise that, under scrutiny, rested on remarkably thin ground.
The supporting study enrolled 160 participants who used the serum for four weeks and were then asked how much younger they thought they looked. No photographs were compared, no dermatologist assessed skin elasticity, and no one used a placebo for comparison. The Advertising Standards Authority also noted that the participants had been recruited without clear criteria and that testing had taken place in a different climate to the UK — casting doubt on whether the results were relevant to British consumers at all.
Beiersdorf argued that the phrase "up to" five years younger was intended to convey a maximum rather than a typical result. The company submitted four pieces of evidence in its defence: three were unpublished, and the fourth, though peer-reviewed, examined an isolated active ingredient rather than the serum itself. The ASA was unconvinced and banned the advert from running in its current form.
Aesthetics marketing expert Lianne Sykes sees the case as a window onto a wider industry habit — dressing subjective impressions in the language of clinical rigour. She argues that meaningful substantiation requires objective skin analysis conducted over time, and that consumers too readily extend trust to familiar brand names without asking how results were measured or who was tested. Beneath the regulatory ruling lies a quieter truth: skin health is shaped by sleep, diet, hydration, and sun protection, not by any single product. When advertising collapses that complexity into a single transformative promise, it is only a matter of time before someone asks for the evidence.
In November 2025, someone saw a billboard at Balham tube station in London advertising a £49 face serum and decided to lodge a complaint. The poster claimed that Eucerin's Hyaluron-Filler Epigenetic Serum was "clinically proven" to make users look up to five years younger. That single complaint set in motion an investigation that would expose how thin the evidence actually was.
The study behind the claim involved 160 people. They used the serum for four weeks. Then they were asked a simple question: how much younger did they think they looked? That was the entire methodology. No one was comparing before-and-after photographs. No dermatologist was measuring skin elasticity or collagen density. The participants simply reported their own impression of their own appearance after a month of use.
The Advertising Standards Authority, Britain's advertising watchdog, found multiple problems with this approach. There was no control group—no one using a placebo serum for comparison. The authority had no information about how the 160 people were recruited in the first place. And crucially, the serum had been tested in a different climate than the UK, raising questions about whether results would transfer to British skin in British weather. The self-reporting itself was inherently subjective. People see what they want to see, especially when they've invested time and money into a product.
Beiersdorf, the company behind Eucerin, defended itself by saying it had presented the claim as "up to" five years younger—language meant to signal that this was a maximum result, not a typical one. The company also submitted three additional pieces of evidence to support its claims. All three were unpublished research. The fourth piece of evidence was a peer-reviewed study, which sounds more rigorous until you learn that it tested the active ingredient in isolation, not the actual serum product that people were buying.
The ASA's conclusion was straightforward: the advert was misleading. It cannot appear in the same form again. Beiersdorf said the billboard was already no longer live in the UK and that all its studies were conducted according to industry standards.
Lianne Sykes, an aesthetics marketing expert who advises companies on ethical advertising, sees this as symptomatic of a broader problem in the cosmetics industry. She argues that proper substantiation requires skin analysis conducted over time, not just self-reported impressions after four weeks. She points out that consumers often accept beauty claims simply because they come with nice branding and recognizable brand names, without asking the obvious questions: How exactly is skin quality being measured? Were all age groups tested, or just a narrow demographic? What does success actually look like, and who decides?
The deeper issue, Sykes suggests, is that skin health is rarely the result of a single product. It emerges from a cluster of habits—sleep, hydration, sun protection, diet, stress management. A serum might contribute to that picture, but it cannot do the work alone. The advertising industry, however, has long been built on the promise of transformation through a single purchase. That promise, when it rests on studies as flimsy as this one, eventually catches the attention of someone willing to complain.
Citas Notables
Beiersdorf said it presented the claim as 'up to' five years younger to reflect a genuine maximum rather than a typical result— Beiersdorf, in response to ASA investigation
Consumers should ask how skin quality is being assessed, whether testing covered all age groups, and how success was measured— Lianne Sykes, aesthetics marketing expert
La Conversación del Hearth Otra perspectiva de la historia
Why did one person's complaint matter enough to trigger a full investigation?
Because the ASA takes its job seriously. A single complaint about a specific, measurable claim—"five years younger"—is enough to warrant scrutiny. The claim is either true or it isn't.
But couldn't Beiersdorf argue that 160 people did feel younger after four weeks?
They could, and they did. But feeling younger and looking younger are different things. The study never measured actual changes to skin. It just asked people how they perceived themselves. That's not evidence; that's hope.
What would a proper study have looked like?
A control group using a placebo serum. Objective measurements—photographs, skin texture analysis, elasticity testing. Testing in the actual climate where the product would be used. And results measured over a realistic timeframe, not just four weeks.
Is Beiersdorf uniquely bad at this, or is this how the industry works?
This is how much of the industry works. The cosmetics sector has a long history of making claims that sound scientific without the rigor to back them up. It's profitable to be vague and hopeful.
What should someone do if they see a serum ad claiming dramatic results?
Ask the questions Sykes mentioned. How was skin quality measured? Were all skin types tested? Is this a maximum result or a typical one? And remember that no serum works alone.